Article Details
Retrieved on: 2021-12-06 17:02:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pharmorage will first target mRNA vaccines: eying up a market expected to reach $23bn USD by 2035. One of its goals will be to target unwanted side- ...
Article found on: www.biopharma-reporter.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here